{"log_id": 802096656055829408, "direction": 0, "words_result_num": 36, "words_result": [{"probability": {"variance": 0.007958, "average": 0.920128, "min": 0.795296}, "location": {"width": 98, "top": 144, "height": 36, "left": 105}, "words": "【禁忌"}, {"probability": {"variance": 0.021386, "average": 0.910038, "min": 0.404735}, "location": {"width": 1245, "top": 196, "height": 61, "left": 169}, "words": "对本品有效成分、其亡需帕霉素衍生物或本品中任一辆料过敏老禁用。在使用依莫司和其它雷帕素"}, {"probability": {"variance": 0.02652, "average": 0.908809, "min": 0.353224}, "location": {"width": 1266, "top": 253, "height": 57, "left": 114}, "words": "衍生物患者中已观察到的过敏反应表现包括色不限于:过敏、呼吸困难、红、胸或血管性水肿(例如"}, {"probability": {"variance": 0.013297, "average": 0.950273, "min": 0.528894}, "location": {"width": 486, "top": 308, "height": 43, "left": 112}, "words": "伴或不伴呼吸功能不全的气道或舌肿服"}, {"probability": {"variance": 0.003221, "average": 0.970053, "min": 0.856572}, "location": {"width": 150, "top": 411, "height": 34, "left": 102}, "words": "〖注意事项"}, {"probability": {"variance": 0.024557, "average": 0.908448, "min": 0.596301}, "location": {"width": 166, "top": 466, "height": 34, "left": 114}, "words": "非感染性炎"}, {"probability": {"variance": 0.026165, "average": 0.893207, "min": 0.448392}, "location": {"width": 1238, "top": 521, "height": 54, "left": 164}, "words": "非感染性肺炎是雷帕霉素衍生物(包括品》的类效应。在临床试验中。点品治疗患者中有19%的思"}, {"probability": {"variance": 0.023275, "average": 0.901979, "min": 0.407174}, "location": {"width": 1296, "top": 573, "height": 59, "left": 109}, "words": "者报告丰感染性静炎。常见药物废应标准(CTC3级和4级的感染性防炎发生率分别为4.0%和0.2%"}, {"probability": {"variance": 0.019185, "average": 0.917754, "min": 0.532862}, "location": {"width": 523, "top": 630, "height": 43, "left": 118}, "words": "(参见《不良反应】)。普观察到个例死亡"}, {"probability": {"variance": 0.022794, "average": 0.914543, "min": 0.392164}, "location": {"width": 1238, "top": 685, "height": 54, "left": 164}, "words": "有非特异性呼吸系统体征和症状(如缺氧、胸胶积液、咳或呼吸困难)的患者并经相应检查排除了"}, {"probability": {"variance": 0.002011, "average": 0.968095, "min": 0.81504}, "location": {"width": 1293, "top": 738, "height": 57, "left": 107}, "words": "感染,肿和其它原因,应考虑华感染性肺炎的诊断。知患者要迅报告任何新出现的或加重的呼吸道"}, {"probability": {"variance": 0, "average": 0.999705, "min": 0.999705}, "location": {"width": 54, "top": 797, "height": 29, "left": 107}, "words": "状"}, {"probability": {"variance": 0.029224, "average": 0.90457, "min": 0.36992}, "location": {"width": 1209, "top": 848, "height": 54, "left": 160}, "words": "放射学改变提示有非感染性肺炎患者仅有极少(或没有》状时,可续本品治疗无需调整剂量"}, {"probability": {"variance": 0.015452, "average": 0.952809, "min": 0.44877}, "location": {"width": 562, "top": 902, "height": 43, "left": 102}, "words": "影像学检查似过高估计了临床肺炎的发生率"}, {"probability": {"variance": 0.023741, "average": 0.929536, "min": 0.384638}, "location": {"width": 1236, "top": 957, "height": 54, "left": 157}, "words": "如果为中度症状,考忠中治疗直至症状改善。可考虑使用皮类醇。可以按之前所用剂量的大约"}, {"probability": {"variance": 0.026241, "average": 0.886126, "min": 0.491962}, "location": {"width": 525, "top": 1012, "height": 41, "left": 130}, "words": "半新开始本品治疗(参见【用法用量】"}, {"probability": {"variance": 0.009764, "average": 0.935543, "min": 0.632891}, "location": {"width": 1241, "top": 1067, "height": 54, "left": 155}, "words": "对于4级非感染性肺炎病例,停止本品治疗。可考虑使用皮类固醇百至临床症状缓解。对于3级非感"}, {"probability": {"variance": 0.019638, "average": 0.920664, "min": 0.391684}, "location": {"width": 1289, "top": 1124, "height": 50, "left": 105}, "words": "染性肺炎,应中断本品治疗直至缓解至≤1级。根据个体患者的临床状况:可以按之前所剂量的大约一半"}, {"probability": {"variance": 0.028745, "average": 0.897326, "min": 0.361934}, "location": {"width": 1293, "top": 1177, "height": 54, "left": 100}, "words": "重新开始本品治疗(参见【用法用】)。如果再次发生级事件,考虑终止本品治疗即使在减量的情"}, {"probability": {"variance": 0.044981, "average": 0.851499, "min": 0.367146}, "location": {"width": 308, "top": 1234, "height": 34, "left": 98}, "words": "况下亦有发生肺炎的告"}, {"probability": {"variance": 8e-06, "average": 0.994388, "min": 0.991481}, "location": {"width": 59, "top": 1289, "height": 34, "left": 96}, "words": "感染"}, {"probability": {"variance": 0.022583, "average": 0.909853, "min": 0.42246}, "location": {"width": 1238, "top": 1341, "height": 52, "left": 150}, "words": "只免疫抑制,因此患者易于感染细菌、真菌、病毒或原虫,包括机会致求导的感染(参见"}, {"probability": {"variance": 0.024809, "average": 0.906937, "min": 0.39091}, "location": {"width": 1250, "top": 1396, "height": 52, "left": 102}, "words": "【不良反应】):曾在使用本品治疗的患老中授告过局部染和全身性的感染(包括肺炎、分技杆感染)"}, {"probability": {"variance": 0.023512, "average": 0.91335, "min": 0.358079}, "location": {"width": 1293, "top": 1451, "height": 52, "left": 96}, "words": "其它细感染和人性真菌感染(如曲霉菌病念珠菌病)、病毒感染(包括乙型肝炎病毒再激活)。少数"}, {"probability": {"variance": 0.026805, "average": 0.89326, "min": 0.423532}, "location": {"width": 742, "top": 1508, "height": 43, "left": 93}, "words": "为重度(例如导致旅毒症,呼吸衰或肝竭)或致命性感染"}, {"probability": {"variance": 0.001166, "average": 0.985308, "min": 0.796961}, "location": {"width": 1241, "top": 1563, "height": 50, "left": 146}, "words": "医师和患者应该知道使用本品治疗会增加感染的风险。在开始本品治疗前应底治疗已经存在的侵入性"}, {"probability": {"variance": 0.026109, "average": 0.902966, "min": 0.414418}, "location": {"width": 1291, "top": 1616, "height": 52, "left": 93}, "words": "真茵感染。服用本品时应警惕染的症状和体征:如果诊断为感染,商迅速开始应的治疗并考虑中断或停"}, {"probability": {"variance": 0.017823, "average": 0.927123, "min": 0.366909}, "location": {"width": 1149, "top": 1671, "height": 50, "left": 91}, "words": "止本品的治疗。如果诊断为侵入性全真闻感染,应立即停止本品治疗并进行应的抗真菌治疗"}, {"probability": {"variance": 0.000899, "average": 0.972799, "min": 0.921074}, "location": {"width": 112, "top": 1728, "height": 32, "left": 89}, "words": "口腔溃疡"}, {"probability": {"variance": 0.026797, "average": 0.897602, "min": 0.407716}, "location": {"width": 1216, "top": 1780, "height": 52, "left": 141}, "words": "在用本品治疗忠者中曾发口腔溃、口腔炎和口腔粘膜炎。在临床试验中,发生率大约为44-86%"}, {"probability": {"variance": 0.029494, "average": 0.886772, "min": 0.403847}, "location": {"width": 1284, "top": 1837, "height": 48, "left": 89}, "words": "4%~%的患者报告了3做或4级口炎(参见【不良反应】)。对于此类病例,建议使局部治疗,但含"}, {"probability": {"variance": 0.010869, "average": 0.930754, "min": 0.533899}, "location": {"width": 1293, "top": 1890, "height": 52, "left": 84}, "words": "精、过氧化物、或百里香的瀚口液会病情,应避免使用。除非诊断为真菌感染,否则不应使用抗真菌"}, {"probability": {"variance": 0.008619, "average": 0.92602, "min": 0.678232}, "location": {"width": 345, "top": 1947, "height": 34, "left": 84}, "words": "药(参见【药物相互作用】)"}, {"probability": {"variance": 0.012955, "average": 0.933026, "min": 0.66282}, "location": {"width": 194, "top": 2002, "height": 36, "left": 84}, "words": "肾功能衰竭事件"}, {"probability": {"variance": 0.015402, "average": 0.92575, "min": 0.499181}, "location": {"width": 1241, "top": 2057, "height": 52, "left": 134}, "words": "在本品治疗的患者中观察到肾衰病例(包括急性肾章),有些可导致死亡。对于存在可能会进一步损害"}, {"probability": {"variance": 0.004824, "average": 0.967244, "min": 0.658259}, "location": {"width": 994, "top": 2112, "height": 48, "left": 80}, "words": "肾功能的其它风险因素的患者,尤其应监测肾功能(参见“实验室检查和监测”)"}], "language": 3}